
InspectIR Systems is pioneering the use of machine learning and mass spectroscopy for breath and environmental analysis, VOC detection and chemical identification. Founded in 2015, the company provides cutting-edge analytical solutions to sectors like healthcare, corrections, law enforcement, and pharmaceuticals. Their patented miniaturized mass spectrometers enable real-time laboratory-level diagnosis outside traditional lab settings, empowering professionals with critical chemical information at the point of need. With a focus on continuous innovation, InspectIR aims to make mass spectroscopy more accessible and usable in real-world applications, improving health, safety, and efficiency across various fields.

InspectIR Systems is pioneering the use of machine learning and mass spectroscopy for breath and environmental analysis, VOC detection and chemical identification. Founded in 2015, the company provides cutting-edge analytical solutions to sectors like healthcare, corrections, law enforcement, and pharmaceuticals. Their patented miniaturized mass spectrometers enable real-time laboratory-level diagnosis outside traditional lab settings, empowering professionals with critical chemical information at the point of need. With a focus on continuous innovation, InspectIR aims to make mass spectroscopy more accessible and usable in real-world applications, improving health, safety, and efficiency across various fields.
What they do: Miniaturized portable mass-spectrometry devices for breath and environmental chemical analysis
Flagship product: PNY-1000 portable mass spectrometer
Notable milestone: Received an FDA Emergency Use Authorization for a breath device (EUA granted 2022-04-14)
Founded: 2015 (company materials present inconsistent years)
Funding signal: Bootstrapped with $2.7M from founders' network and angel investors
Real-time chemical detection and diagnostics outside laboratory settings (breath VOCs, illicit drugs, explosives, environmental VOCs).
2015
Data and Analytics
“Bootstrapped with $2.7M from family, friends and a handful of angel investors; no institutional VC disclosed”